Vector Biomed is a private other pharmaceuticals and biotechnology company. It has raised $15 million across 1 recorded round; the latest was a $15 million Series A in Jan 2023.
Last price · $/share
—
Implied valuation
—
Total raised
$15.0M
Last round
Early Stage VC (Series A)
Jan 2023
Investors — not yet on record
No investors in Vector Biomed are on record yet. Backers surface from round announcements, filings, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vector Biomed with a free account
·Watch Vector Biomed: the Monday email on marks, rounds and moves
